Multidrug Resistance in the 2020's: A Threat in the Hospital and in the Community

Dear Colleagues,

Multidrug Resistance represent a major concern for public health and the pressure for hospitals and communities. During the ongoing COVID-19 pandemic, antibiotics and antifungals have been extensively used for the management of hospitalized patients infected with SARS-CoV-2. Unintended consequences of antimicrobial overuse include, among others, the increment of resistance and the circulation of multidrug-resistant organisms (MDROs). On the other hand, the management of hospitalized SARS-CoV-2 patients increases the risk of outbreak due to MDROs for several reasons, including the increased number of patients, increased length of hospital stay, extensive antibiotic use, lack of infection prevention and control measures and interruption of antimicrobial stewardship programs.

In this Special Issue, we encourage colleagues to submit manuscripts related to the multidrug-resistant pathogens and relevant treatment—from hospital to communities. We also welcome manuscripts describing new methods and the adaption or creation of technologies for the study, prevention, and control of multidrug resistance.

Dr. Despoina Koulenti
Prof. Dr. Stijn Blot
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.